Literature DB >> 9068731

The impact of chronic urticaria on the quality of life.

B F O'Donnell1, F Lawlor, J Simpson, M Morgan, M W Greaves.   

Abstract

The impact of chronic urticaria (CU) on the quality of life is undocumented. We assessed quality of life in patients with CU, including patients with associated delayed pressure urticaria (DPU). One hundred and forty-two out-patients completed self-administered questionnaires: a disease-specific, purpose designed questionnaire, and the Nottingham health profile (NHP). Many patients reported problems attributable to their skin condition in facets of everyday life including home management, personal care, recreation and social interaction, mobility, emotional factors, sleep, rest and work. The NHP part I scores showed restriction in the areas of mobility, sleep, energy, and demonstrated pain, social isolation and altered emotional reactions. Part II of the NHP showed that patients experienced difficulties in relation to work, looking after the home, social life, home relationships, sex life, hobbies and holidays. The patients with DPU had significantly more problems with mobility, gardening and choice of clothing than the uncomplicated CU patients. They also suffered more pain, had more problems with work and were more restricted in their hobbies.

Entities:  

Mesh:

Year:  1997        PMID: 9068731

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  109 in total

1.  A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology.

Authors:  A G de Tiedra; J Mercadal; X Badía; J M Mascaró; R Lozano
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

2.  [Physical urticaria].

Authors:  M Fleischer; J Grabbe
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

3.  The role of autoimmune testing in chronic idiopathic urticaria.

Authors:  Ravi K Viswanathan; Mark J Biagtan; Sameer K Mathur
Journal:  Ann Allergy Asthma Immunol       Date:  2012-03-21       Impact factor: 6.347

4.  Patients' perception of the value of levocetirizine in allergic diseases : a multicentre observational study in Germany.

Authors:  L Klimek; H Wrede; B C Schott; I Hansen
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

Review 5.  The urticarias: pathophysiology and management.

Authors:  Clive Grattan
Journal:  Clin Med (Lond)       Date:  2012-04       Impact factor: 2.659

6.  Retrospective analysis of the efficacy of omalizumab in chronic refractory urticaria.

Authors:  Ravi K Viswanathan; Mark H Moss; Sameer K Mathur
Journal:  Allergy Asthma Proc       Date:  2013 Sep-Oct       Impact factor: 2.587

Review 7.  Chronic Urticaria: Comparisons of US, European, and Asian Guidelines.

Authors:  S Shahzad Mustafa; Mario Sánchez-Borges
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-24       Impact factor: 4.806

Review 8.  Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications.

Authors:  Massimo Cugno; Angelo V Marzano; Riccardo Asero; Alberto Tedeschi
Journal:  Intern Emerg Med       Date:  2009-12-01       Impact factor: 3.397

9.  Desloratadine for the Relief of Nasal and Non-nasal Allergy Symptoms: An Observational Study.

Authors:  Werner Aberer
Journal:  Arch Drug Inf       Date:  2009-06

10.  Chronic autoimmune urticaria: where we stand?

Authors:  C L Goh; K T Tan
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.